CLINICAL_TRIALS
trial_result
· 2010-04-09
Clinical Trial Update: Effect of LY686017 on Alcohol Craving [Phase 2]
Summary
A Phase 2 trial evaluating LY686017 for reducing alcohol craving in adults with alcohol use disorder has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Dependence, Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2010-04-09